SVP and CFO of Hospira Inc. (HSP, Financial) Thomas E Werner buys 1,000 shares of HSP on 08/05/2009 at an average price of $38.9 a share.
Hospira Inc is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness by developing manufacturing and marketing products that help improve the safety and efficacy of patient care. Their portfolio includes one of the industry\'s broadest lines of generic acute-care injectables integrated solutions for medication management and infusion therapy and a full-service contract manufacturing business. Hospira Inc. has a market cap of $6.24 billion; its shares were traded at around $38.88 with a P/E ratio of 14.2 and P/S ratio of 1.7.
HSP is in the portfolios of Robert Olstein of Olstein Financial Alert Fund, John Rogers of ARIEL CAPITAL MANAGEMENT LLC, Robert Bruce of Bruce & Co., Inc., Edward Owens of Vanguard Health Care Fund.
Recent Trades of Hospira Inc. by Directors and Officers:
Hospira Inc is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness by developing manufacturing and marketing products that help improve the safety and efficacy of patient care. Their portfolio includes one of the industry\'s broadest lines of generic acute-care injectables integrated solutions for medication management and infusion therapy and a full-service contract manufacturing business. Hospira Inc. has a market cap of $6.24 billion; its shares were traded at around $38.88 with a P/E ratio of 14.2 and P/S ratio of 1.7.
HSP is in the portfolios of Robert Olstein of Olstein Financial Alert Fund, John Rogers of ARIEL CAPITAL MANAGEMENT LLC, Robert Bruce of Bruce & Co., Inc., Edward Owens of Vanguard Health Care Fund.
Recent Trades of Hospira Inc. by Directors and Officers:
- Buy: SVP, Global Marketing Ron Squarer bought 3,000 shares of HSP stock on 02/25/2009 at the average price of $24.8; the price of the stock has increased by 56.77% since.
- Buy: SVP, General Counsel and Sec. Brian J Smith bought 10 shares of HSP stock on 02/23/2009 at the average price of $25.39; the price of the stock has increased by 53.13% since.